SCHEMBL5753291

SCHEMBL5753291

CC(C)C(C#N)(CCCN1CCN(CCOc2ccccc2C#N)CC1)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CACNA1B Q00975 3/20 0.48
HTR1A P08908 4/20 0.47
HTR7 P34969 2/20 0.47
MEN1 O00255 3/20 0.46
KMT2A Q03164 2/20 0.46
EBP Q15125 2/20 0.42
SIGMAR1 Q99720 2/20 0.42
LMNA P02545 1/20 0.42
POLB P06746 1/20 0.42
CCR3 P51677 1/20 0.42
HTR2A P28223 3/20 0.41
DRD2 P14416 2/20 0.41
ALDH1A1 P00352 1/20 0.41
RAB9A P51151 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HTR2C P28335 1/20 0.39
USP2 O75604 1/20 0.38
MAPK1 P28482 1/20 0.38
CCR1 P32246 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5751449 0.88 KDM4E (0.48) CACNA1BMEN1KMT2AEBPSIGMAR1
SCHEMBL5749773 0.88 CACNA1B (0.48) CACNA1BHTR1AHTR7MEN1KMT2A
SCHEMBL5754333 0.86 CACNA1B (0.58) CACNA1BHTR1AMEN1KMT2AEBP
SCHEMBL5752954 0.86 MEN1 (0.53) CACNA1BHTR7MEN1KMT2APOLB
SCHEMBL5753612 0.85 HRH1 (0.55) CACNA1BEBPSIGMAR1CCR3DRD2
SCHEMBL5752204 0.85 CACNA1B (0.52) CACNA1BHTR1AHTR7MEN1KMT2A
SCHEMBL5754105 0.84 MEN1 (0.59) CACNA1BMEN1KMT2A
SCHEMBL14431859 0.84 CCR3 (0.54) CACNA1BHTR1AEBPSIGMAR1CCR3
SCHEMBL2866236 0.84 CACNA1B (0.52) CACNA1BHTR1AHTR7MEN1KMT2A
SCHEMBL5754583 0.83 CACNA1B (0.47) CACNA1BMEN1EBPSIGMAR1CCR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1099692-B1 N,N-SUBSTITUTED CYCLIC AMINE DERIVATIVES EISAI CO LTD (JP) 2006-05-03 EP claimed
US-6737425-B1 SUCH AS 1-((4-CYANO-5-METHYL-4-PHENYL)HEXYL)-4-(2-(4-FLUORO -PHENOXY)ETHYL)PIPERAZINE; NERVE SELECTIVE CALCIUM ANTAGONISTS EISAI CO., LTD. (JP) 2004-05-18 US claimed
EP-1099692-A1 N,N-SUBSTITUTED CYCLIC AMINE DERIVATIVES Eisai Co., Ltd. (JP) 2001-05-16 EP claimed
EP-1716118-A1 TETRAHYDROBENZO[D]AZEPIN-2- ONE DERIVATIVES AND THE USE THEREOF FOR TREATING CARDIOVASCULAR DISEASES Bayer HealthCare AG (DE) 2006-11-02 EP disclosed
EP-1099692-B1 N,N-SUBSTITUTED CYCLIC AMINE DERIVATIVES EISAI CO LTD (JP) 2006-05-03 EP disclosed
WO-2005077907-A1 TETRAHYDROBENZO[D]AZEPIN-2- ONE DERIVATIVES AND THE USE THEREOF FOR TREATING CARDIOVASCULAR DISEASES BAYER HEALTHCARE AG (DE) 2005-08-25 WO disclosed
US-6737425-B1 SUCH AS 1-((4-CYANO-5-METHYL-4-PHENYL)HEXYL)-4-(2-(4-FLUORO -PHENOXY)ETHYL)PIPERAZINE; NERVE SELECTIVE CALCIUM ANTAGONISTS EISAI CO., LTD. (JP) 2004-05-18 US disclosed
EP-1099692-A1 N,N-SUBSTITUTED CYCLIC AMINE DERIVATIVES Eisai Co., Ltd. (JP) 2001-05-16 EP disclosed